Attribution of ghrelin to cancer; Attempts to unravel an apparent controversy

Authors

Saeed Soleyman-Jahi, Washington University School of Medicine in St. Louis
Fatemeh Sadeghi, Tehran University of Medical Sciences
Amin Pastaki Khoshbin, Tehran University of Medical Sciences
Leila Khani, Iran University of Medical Sciences
Venus Roosta, Tehran University of Medical Sciences
Kazem Zendehdel, Tehran University of Medical Sciences

Journal

Frontiers in oncology

Publication Date

1-1-2019

Volume

9

First Page

1014

Document Type

Open Access Publication

DOI

10.3389/fonc.2019.01014

Rights and Permissions

Soleyman-Jahi S, Sadeghi F, Pastaki Khoshbin A, Khani L, Roosta V, Zendehdel K. Attribution of Ghrelin to Cancer; Attempts to Unravel an Apparent Controversy. Front Oncol. 2019;9:1014. doi: 10.3389/fonc.2019.01014. Copyright © 2019 Soleyman-Jahi, Sadeghi, Pastaki Khoshbin, Khani, Roosta and Zendehdel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Soleyman-Jahi, Saeed; Sadeghi, Fatemeh; Pastaki Khoshbin, Amin; Khani, Leila; Roosta, Venus; and Zendehdel, Kazem, "Attribution of ghrelin to cancer; Attempts to unravel an apparent controversy." Frontiers in oncology. 9, 1014 (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8620